Further studies have shown that apigenin decreases the nuclear level of β-catenin and increases the cytoplasmic level of E-cadherin in prostate cancer DU145 cells in vitro and in prostate tumors from TRAMP mice in vivo (Shukla et al., 2007). The gene discussed is CDH1; the disease is prostate carcinoma.